Dr. Michael Jain

Dr. Michael Jain

Medical Oncologist
Moffitt Cancer Center

Dr. Michael Jain is an assistant member in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr. Jain earned his medical degree at McGill University in Montréal, Canada, and completed both his internal medicine and hematology residencies at the University of Toronto.

Dr. Jain's clinical focus is on treatments for relapsed lymphoma, particularly stem cell transplantation, cellular therapies, and immunotherapies. His research interests include lymphoma and early-phase clinical trials.

Recurrence

CAR T-Cell Therapy Side Effects Can Be Serious, But Many Are Short-Lived

Recurrence

When Non-Hodgkin Lymphoma Relapses: How Chemotherapy Can Help

Treatment

Lenalidomide (Revlimid): Stimulating Your Immune System to Shrink Your Cancer

Treatment

Why Clinical Trials for Diffuse Large B-Cell Lymphoma Are So Important

Recurrence

CAR T-Cell Therapy: Making Your Body a More Efficient Cancer Fighter

Treatment

You May Have Side Effects Years After Non-Hodgkin Lymphoma Treatment: Here’s What to Watch For

Living With Cancer

Non-Hodgkin Lymphoma Treatment — and Beyond

Recurrence

Treatment After Relapse: Combatting Non-Hodgkin Lymphoma the Second Time Around

Recurrence

What’s the Risk of Relapse After Non-Hodgkin Lymphoma Treatment?

Prevention & Risk

Age, Race, and Exposures Might All Factor Into Lymphoma Risk

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider